Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New radiation combo for tough lymphoma shows early promise but trial halted

NCT ID NCT05994157

First seen Mar 28, 2026 · Last updated May 23, 2026 · Updated 5 times

Summary

This early-phase trial tested a two-step radiation treatment for people with non-Hodgkin lymphoma that had come back or stopped responding to standard therapies. The approach uses a targeting molecule to deliver a radioactive payload directly to cancer cells. Only one person was enrolled before the study was terminated, so no conclusions about safety or effectiveness can be drawn.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-HODGKIN LYMPHOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • City of Hope

    Duarte, California, 91010, United States

  • Corewell Health-BAMF Health

    Grand Rapids, Michigan, 49503, United States

  • East Carolina University Leo W. Jenkins Cancer Center

    Greenville, North Carolina, 27834, United States

  • HonorHealth

    Scottsdale, Arizona, 85258, United States

  • Memorial Sloan Kettering Cancer Center

    New York, New York, 10065, United States

  • Stony Brook Cancer Center

    Stony Brook, New York, 11794, United States

Conditions

Explore the condition pages connected to this study.